Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders

Chronic kidney disease (CKD) is a rapidly rising global health burden that affects nearly 40% of older adults. Epidemiologic data suggest that individuals at all stages of chronic kidney disease (CKD) have a higher risk of developing cognitive disorders and dementia, and thus represent a vulnerable...

Full description

Bibliographic Details
Main Authors: Kelly, D.M (Author), Rothwell, P.M (Author)
Format: Article
Language:English
Published: Frontiers Media S.A. 2022
Subjects:
age
CKD
Online Access:View Fulltext in Publisher
LEADER 02750nam a2200625Ia 4500
001 10-3389-fneur-2022-830064
008 220420s2022 CNT 000 0 und d
020 |a 16642295 (ISSN) 
245 1 0 |a Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders 
260 0 |b Frontiers Media S.A.  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.3389/fneur.2022.830064 
520 3 |a Chronic kidney disease (CKD) is a rapidly rising global health burden that affects nearly 40% of older adults. Epidemiologic data suggest that individuals at all stages of chronic kidney disease (CKD) have a higher risk of developing cognitive disorders and dementia, and thus represent a vulnerable population. It is currently unknown to what extent this risk may be attributable to a clustering of traditional risk factors such as hypertension and diabetes mellitus leading to a high prevalence of both symptomatic and subclinical ischaemic cerebrovascular lesions, or whether other potential mechanisms, including direct neuronal injury by uraemic toxins or dialysis-specific factors could also be involved. These knowledge gaps may lead to suboptimal prevention and treatment strategies being implemented in this group. In this review, we explore the mechanisms of susceptibility and risk in the relationship between CKD and cognitive disorders. Copyright © 2022 Kelly and Rothwell. 
650 0 4 |a age 
650 0 4 |a Alzheimer disease 
650 0 4 |a amyloid beta protein 
650 0 4 |a antihypertensive agent 
650 0 4 |a anxiolytic agent 
650 0 4 |a cerebrovascular accident 
650 0 4 |a cerebrovascular disease 
650 0 4 |a chronic kidney failure 
650 0 4 |a CKD 
650 0 4 |a cognitive defect 
650 0 4 |a cognitive impairment 
650 0 4 |a dementia 
650 0 4 |a dementia 
650 0 4 |a depression 
650 0 4 |a diabetes mellitus 
650 0 4 |a dialysis 
650 0 4 |a disease association 
650 0 4 |a disease predisposition 
650 0 4 |a drug use 
650 0 4 |a educational status 
650 0 4 |a hemodialysis 
650 0 4 |a hemodialysis patient 
650 0 4 |a heredity 
650 0 4 |a high risk population 
650 0 4 |a human 
650 0 4 |a hypertension 
650 0 4 |a hypertension 
650 0 4 |a kidney transplantation 
650 0 4 |a mild cognitive impairment 
650 0 4 |a nervous system inflammation 
650 0 4 |a obesity 
650 0 4 |a pathogenesis 
650 0 4 |a peritoneal dialysis 
650 0 4 |a prevalence 
650 0 4 |a Review 
650 0 4 |a risk factor 
650 0 4 |a sex difference 
650 0 4 |a sleep disorder 
650 0 4 |a stroke 
650 0 4 |a uremia 
700 1 0 |a Kelly, D.M.  |e author 
700 1 0 |a Rothwell, P.M.  |e author 
773 |t Frontiers in Neurology